The National Stock Exchange of India (NSE) has announced a significant change in the expiry day of index and stock derivatives contracts. This revision, set to take effect from April 04, 2025, aims to streamline trading operations and enhance market efficiency. Understanding these changes is crucial for traders and investors actively participating in the Futures & Options (F&O) segment.
NSE has modified the expiry schedule for several derivatives contracts.
These changes impact all existing contracts extending beyond April 03, 2025, and any new contracts created from April 04, 2025.
The shift to Monday expiries benefits the derivatives market in multiple ways. It aligns with global trading practices and helps reduce disruptions caused by weekly holidays. Managing open positions also becomes easier at the start of the week, leading to improved liquidity. Another advantage is the reduced risk of overlapping with major domestic and global events, which typically take place later in the week. Moreover, traders and institutional investors gain extra time during the weekend to assess market movements and fine-tune their strategies, ultimately enhancing their risk management.
The final expiry under the current schedule will be on Thursday, April 03, 2025. Starting on April 04, 2025, all newly created contracts will follow the revised Monday expiry schedule. An updated contract file reflecting these changes will be available by the end of the day (EOD) on April 03, 2025.
Active traders in the F&O market must adjust their trading strategies to align with the new expiry schedule. Since weekly and monthly expiries will now fall on Mondays, risk management and hedging strategies need to be adjusted accordingly. Traders should also update their trading calendars to ensure they do not miss crucial deadlines.
Additionally, the Clearing Corporations will release revised settlement schedules, so traders must stay informed about changes in fund settlements and margin requirements. Another essential factor to consider is weekend market developments, which could lead to increased volatility on Monday mornings. It is advisable that traders incorporate structured weekend risk assessment into their strategy.
The change in expiry days may initially bring adjustments in trading volumes and pricing behavior. Short-term volatility is expected, as traders adapt to the new schedule. However, in the long-term, the revised expiry structure is likely to create a more streamlined/efficient trading environment.
Moreover, institutional investors and proprietary traders may benefit from reduced market overlaps with key macroeconomic events. This will allow for more strategic positioning in derivatives contracts, improving overall market efficiency and liquidity.
The NSE’s decision to revise expiry days for index and stock derivatives is a strategic move to optimise trading efficiency and risk management. With expiring moving to Mondays, traders and investors should focus on adapting their trading calendars, reassessing volatility patterns, and staying updated on settlement processes. As always, staying informed and adaptable will be key to making the most of these changes in the trading landscape.
Source: [SEBI Circular](C:\Users\shupal2\AppData\Local\Microsoft\Olk\Others\Futures and Options_Circular_04_03_2025.pdf)
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.